| __timestamp | Galapagos NV | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 111110000 | 13673000 |
| Thursday, January 1, 2015 | 129714000 | 14358000 |
| Friday, January 1, 2016 | 139574000 | 12203000 |
| Sunday, January 1, 2017 | 218502000 | 18125000 |
| Monday, January 1, 2018 | 322876000 | 17071000 |
| Tuesday, January 1, 2019 | 427320000 | 20018000 |
| Wednesday, January 1, 2020 | 523667000 | 32788000 |
| Friday, January 1, 2021 | 491707000 | 44966000 |
| Saturday, January 1, 2022 | 515083000 | 311681000 |
| Sunday, January 1, 2023 | 241294000 | 77707000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology and pharmaceuticals, innovation is the lifeblood of progress. Galapagos NV and Lantheus Holdings, Inc. have been at the forefront of this innovation race, each with distinct strategies and outcomes. Over the past decade, Galapagos NV has consistently outpaced Lantheus in research and development (R&D) spending, peaking in 2020 with a staggering 523% increase from 2014. However, 2022 marked a turning point for Lantheus, with a dramatic surge in R&D expenses, reaching 311 million, a 1,200% increase from its 2014 figures. This shift highlights Lantheus's commitment to bolstering its innovation pipeline. As we look to the future, the question remains: will Lantheus maintain this momentum, or will Galapagos reclaim its lead? The stakes are high, and the race for innovation supremacy continues.
R&D Spending Showdown: Amgen Inc. vs Lantheus Holdings, Inc.
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Lantheus Holdings, Inc.
Comparing Innovation Spending: Gilead Sciences, Inc. and Galapagos NV
Research and Development: Comparing Key Metrics for Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc.
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Galapagos NV
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Madrigal Pharmaceuticals, Inc. vs Galapagos NV
TG Therapeutics, Inc. or Galapagos NV: Who Invests More in Innovation?
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Galapagos NV
R&D Spending Showdown: Mesoblast Limited vs Galapagos NV